Gladden Brian T 4

What Happened

• Brian T. Gladden, a director of DENTSPLY SIRONA Inc. (XRAY), acquired 9,985.022 shares in an open-market purchase on 2026-06-15. The filing reports a weighted-average price of $10.02 per share, for an aggregate cost of roughly $100,000. This was a direct purchase (transaction code P).

Key Details

• Transaction date: 2026-06-15 (Period of Report: 2026-06-15).
• Reported price: weighted average $10.02; footnote states underlying trades ranged from $10.015 to $10.0156.
• Shares acquired: 9,985.022; aggregate reported value ≈ $100,000.
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Filing timeliness: Period of Report matches the transaction date, so the filing appears timely.
• Footnote: Reporting person offers to provide full breakdown of the number of shares purchased at each price within the reported range upon request.

Context

• This was an open-market purchase by a board director (not an option exercise, award, or gift). Purchases by insiders are often watched by investors as a potential positive signal, but they are one data point and do not alone indicate the company’s prospects.